Return On Assets of Bone Biologics Corp from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Bone Biologics Corp quarterly and annual Return On Assets in % history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Bone Biologics Corp Return On Assets for the quarter ending 30 Sep 2025 was -77%, a 31% increase year-over-year.
  • Bone Biologics Corp annual Return On Assets for 2024 was -110%, a 29% increase from 2023.
  • Bone Biologics Corp annual Return On Assets for 2023 was -155%, a 563% decline from 2022.
  • Bone Biologics Corp annual Return On Assets for 2022 was -23%, a 75% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Bone Biologics Corp Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -77% +34% +31% 01 Jul 2025 30 Sep 2025
Q2 2025 -93% +37% +28% 01 Apr 2025 30 Jun 2025
Q1 2025 -119% +1.6% +1.3% 01 Jan 2025 31 Mar 2025
Q4 2024 -110% +45% +29% 01 Oct 2024 31 Dec 2024
Q3 2024 -112% -18% -20% 01 Jul 2024 30 Sep 2024
Q2 2024 -130% -47% -57% 01 Apr 2024 30 Jun 2024
Q1 2024 -121% -52% -76% 01 Jan 2024 31 Mar 2024
Q4 2023 -155% -131% -563% 01 Oct 2023 31 Dec 2023
Q3 2023 -93% -50% -116% 01 Jul 2023 30 Sep 2023
Q2 2023 -83% -43% -107% 01 Apr 2023 30 Jun 2023
Q1 2023 -69% -11% -18% 01 Jan 2023 31 Mar 2023
Q4 2022 -23% +71% +75% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% +5853% +99% 01 Jul 2022 30 Sep 2022
Q2 2022 -40% 01 Apr 2022 30 Jun 2022
Q1 2022 -58% 01 Jan 2022 31 Mar 2022
Q4 2021 -95% 01 Oct 2021 31 Dec 2021
Q3 2021 -5896% 01 Jul 2021 30 Sep 2021
Q1 2020 -1890% -1507% -394% 01 Jan 2020 31 Mar 2020
Q4 2019 -1007% -589% -141% 01 Oct 2019 31 Dec 2019
Q3 2019 -736% -163% -28% 01 Jul 2019 30 Sep 2019
Q2 2019 -362% +588% +62% 01 Apr 2019 30 Jun 2019
Q1 2019 -383% +205% +35% 01 Jan 2019 31 Mar 2019
Q4 2018 -418% +143% +25% 01 Oct 2018 31 Dec 2018
Q3 2018 -574% +154% +21% 01 Jul 2018 30 Sep 2018
Q2 2018 -950% +123% +11% 01 Apr 2018 30 Jun 2018
Q1 2018 -587% +615% +51% 01 Jan 2018 31 Mar 2018
Q4 2017 -561% +713% +56% 01 Oct 2017 31 Dec 2017
Q3 2017 -728% +572% +44% 01 Jul 2017 30 Sep 2017
Q2 2017 -1073% -88% -9% 01 Apr 2017 30 Jun 2017
Q1 2017 -1202% -481% -67% 01 Jan 2017 31 Mar 2017
Q4 2016 -1274% -829% -186% 01 Oct 2016 31 Dec 2016
Q3 2016 -1300% -1111% -589% 01 Jul 2016 30 Sep 2016
Q2 2016 -984% -775% -371% 01 Apr 2016 30 Jun 2016
Q1 2016 -721% -419% -138% 01 Jan 2016 31 Mar 2016
Q4 2015 -445% -40% -9.8% 01 Oct 2015 31 Dec 2015
Q3 2015 -189% +1937% +91% 01 Jul 2015 30 Sep 2015
Q2 2015 -209% +1646% +89% 01 Apr 2015 30 Jun 2015
Q1 2015 -303% +3646% +92% 01 Jan 2015 31 Mar 2015
Q4 2014 -405% +2071% +84% 01 Oct 2014 31 Dec 2014
Q3 2014 -2125% +126761% +98% 01 Jul 2014 30 Sep 2014
Q2 2014 -1855% 01 Apr 2014 30 Jun 2014
Q1 2014 -3949% 01 Jan 2014 31 Mar 2014
Q4 2013 -2476% 01 Nov 2013 31 Jan 2014
Q3 2013 -128886% 01 Jul 2013 30 Sep 2013

Bone Biologics Corp Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -110% +45% +29% 01 Jan 2024 31 Dec 2024
2023 -155% -131% -563% 01 Jan 2023 31 Dec 2023
2022 -23% +71% +75% 01 Jan 2022 31 Dec 2022
2021 -95% 01 Jan 2021 31 Dec 2021
2019 -1007% -589% -141% 01 Jan 2019 31 Dec 2019
2018 -418% +143% +25% 01 Jan 2018 31 Dec 2018
2017 -561% +713% +56% 01 Jan 2017 31 Dec 2017
2016 -1274% -829% -186% 01 Jan 2016 31 Dec 2016
2015 -445% -40% -9.8% 01 Jan 2015 31 Dec 2015
2014 -405% +4484% +92% 01 Jan 2014 31 Dec 2014
2013 -4889% +290189% +98% 01 Jan 2013 31 Dec 2013
2012 -295078% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.